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A B S T R A C T
A cDNA encoding the chicken homologue of the human myelomonocytic differentiation antigen, CD14,
was cloned by RT-PCR from chicken bone marrow cell RNA, using oligonucleotide primers based on the
predicted cDNA sequence. The cloned chicken CD14 (chCD14) cDNA encodes an open reading frame of
465 amino acids (aa), with 31–34% aa identity to mouse, bovine and human (hu) CD14. As in mouse and
man, chCD14 is a leucine-rich protein. In mammals, CD14 is a GPI-anchored protein. Protein structure
analysis suggested that chCD14, by contrast, was potentially a trans-membrane protein. The predicted aa
sequence comprises an extracellular domain of 417 aa, followed by a 23-aa trans-membrane segment,
and a 25-aa intracytoplasmic region, the latter containing no obvious signalling motifs. COS-7 cells were
transfectedwith p3XFLAG-CMVTM-8::chCD14 or pCDM8::huCD14, incubatedwith or without PI-PLC and
stained with anti-FLAG or anti-huCD14 antibody respectively. PI-PLC cleaved huCD14 but not chCD14,
suggesting that chCD14 is not GPI-anchored. Real-time quantitative RT-PCR analysis revealed that
chCD14 mRNA was expressed in most lymphoid and non-lymphoid tissues, except muscle. ChCD14
mRNA was also expressed in most cells examined but strongly expressed in chicken peripheral blood
monocyte/macrophages and KUL01+ splenocytes.
 2008 Elsevier Ltd. All rights reserved.
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CD14 is a myelomonocytic differentiation antigen in mammals
[1]. Human CD14 is a single-copy gene encoding two protein
forms: a 50–55-kDa glycosylphosphatidylinositol (GPI)-anchored
membrane protein (mCD14) and a monocyte or liver-derived
soluble serum protein (sCD14) that lacks the anchor [2–5]. CD14 is
the lipopolysaccharide (LPS)-LPS binding protein (LBP) receptor,
forming a multi-protein complex containing at least CD14, MD-2
and TLR4 [6–8]. The crucial role of CD14 in LPS signalling has been
conﬁrmed with knock-out mice; CD14-deﬁcient mice are highly
resistant to septic shock initiated by injection of either LPS or live
bacteria [9–11]. Both mCD14 and sCD14 are critical for LPS-
dependent signal transduction, and sCD14 confers LPS sensitivity
to cells lacking mCD14. In addition to the LPS of Gram-negative
bacteria, CD14 can bind other microbial products such as
peptidoglycan (PGN) and lipoproteins [12].
CD14 was ﬁrst identiﬁed on the surface of monocytes and
macrophages [13] and ever since CD14 has been widely used as a
monocyte/macrophage marker. Recently it has become clear that* Corresponding author. Tel.: +44 1635 578411; fax: +44 1635 577263.
E-mail address: zhiguang.wu@bbsrc.ac.uk (Z. Wu).
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doi:10.1016/j.dci.2008.07.008CD14 is also expressed by other cells and not even restricted to the
myeloid cell lineage [14]. In mammals, CD14 has been well
characterized [2,15–18] but this molecule has yet to be described
in a non-mammalian species. In this study we report for the ﬁrst
time the identiﬁcation and characterization of chicken CD14
(chCD14).
2. Materials and methods
2.1. Bioinformatic identiﬁcation and cloning of chicken CD14
BLAST was used to search Ensembl and predict the cDNA
sequence of the chicken homologue of the humanmyelomonocytic
differentiation antigen, CD14.
Primers were designed according to the predicted sequence
(Table 1). Primer CD14-1 corresponds to nt positions 29 to 4 of
the coding sequence. Primer CD14-2 is reverse complementary to
nt positions 1391–1413. Nested PCR primer CD14-3 corresponds to
nt positions 1–18 and primer CD14-4 is reverse complementary to
nt positions 1380–1398.
Femurs were dissected from 4-week-old inbred line 72
chickens, the bone marrow was ﬂushed out with PBS using a
syringe and bone marrow cells were isolated by centrifugation
over Histopaque 1.119 (Sigma–Aldrich, Poole, UK). Cells were
Table 1
Primer/probe sequences
Primer/probea Sequence (50-30)
CD14-1 ACCGCCGTCTCCTTCCCAGGCTGCTC
CD14-2 GGACGCCAGGAGCCCTTACAAGT
CD14-3 ATGCGTGGGGCCGCTCTG
CD14-4 TTACAAGTGCTCTGCACCG
CD14-5 ACAAAGCTTCGGTGTGTCTTCAACCGCAC
CD14-6 TCCTCTAGATTACAAGTGCTCTGCACCGC
CD14 F GGACGACTCCACCATTGACAT
CD14 R GGAGGACCTCAGGAACCAGAA
CD14 probe (FAM)-AATGATCTTCCTGATTTGCAGACTGCCAA-(TAMRA)
28S F GGCGAAGCCAGAGGAAACT
28S R GACGACCGATTTGCACGTC
28S probe (FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA)
a F, Taqman forward primer; R, Taqman reverse primer.
Z. Wu et al. / Developmental and Comparative Immunology 33 (2009) 97–10498harvested and total RNA isolated using an RNeasyMini kit (Qiagen,
Crawley, UK), with on-column DNaseI treatment. Separate RNA
preparations were isolated from bonemarrow from three different
birds and RT-PCRswere carried out separately using the RNAs from
these three preparations. First strand synthesis was for 50 min at
42 8C in a 20-ml volume containing 4 pmol of oligo-dT, 200 U
Superscript II (Invitrogen, Paisley, UK) and 500 ng bone marrow
RNA. After denaturation of the reverse transcriptase at 94 8C for
3 min, 2ml of this reaction mix was added as template to a 20-ml
PCR reaction, containing 20 pmol of each primer (CD14-1 and
CD14-2), 0.4 mM dNTPs, 1ml Taq polymerase and 4ml Q solution
(Qiagen). Cycling conditions were 30 cycles of 94 8C for 1 min,
58 8C for 1 min, 72 8C for 1 min. The PCR products were puriﬁed
and primers CD14-3 and CD14-4 were used to reamplify and clone
the entire coding sequence of chCD14 from the initiation to the
stop codons inclusive. The resulting PCR product was ligated into
TOPO pCR2.1 (Invitrogen) and the complete sequence of three
clones determined on each strand. Based on the protein structure
prediction, primers (CD14-5 and CD14-6) were designed to
subclone the cDNA encoding the predicted mature protein of
chCD14 into p3XFLAG-CMVTM-8 for eukaryotic expression. Several
clones of this construct (p3XFLAG-CMVTM-8::chCD14) were
sequenced to conﬁrm the integrity of the inserts. The cDNA
sequence has been submitted to Ensembl with the accession
number AM933591.
2.2. Tissues and cells
Lymphoid (thymus, spleen, bursa, Harderian gland, caecal
tonsil, Meckel’s diverticulum and bone marrow) and non-
lymphoid (brain, muscle, heart, liver, kidney, lung and skin)
tissues were obtained from three 6-week-old inbred line 72
chickens. Different cell populations (splenocytes, splenocytes
stimulated with Concanavalin A [ConA] (1mg/ml), bursal cells,
bursal cells stimulated with phorbol myristate acetate [PMA]
(500 ng/ml), thymocytes, thymocytes stimulated with phytohae-
magglutinin [PHA] (25mg/ml), peripheral blood monocytes and
peripheral blood monocyte-derived macrophages) were obtained
as described before [19]. In order to isolate different lymphocyte
subsets, splenocytes were isolated as described [20]. Brieﬂy,
spleens were digested in Hank’s buffered salt solution (HBSS)
containing 556 mg/ml DNase I (Roche Diagnostics Ltd., Burgess
Hill, West Sussex, UK) and 2.2 mg/ml collagenase D (Roche
Diagnostics Ltd.) for 1 h. Cells were then collected into HBSS
containing 10 mMEDTA and passed through a cell strainer. The cell
suspension was centrifuged at 250  g for 10 min to pellet the
cells. Cells were then resuspended in PBS and layered over 5–7 ml
Histopaque 1.077 (Sigma–Aldrich) followed by centrifugation at
1000  g for 20 min. Cells at the interface were collected, washedand counted. Cells (1  108) were labelled with mouse anti-
chicken CD4, CD8, Bu-1, TCR1, TCR2, TCR3, or KUL01 monoclonal
antibodies (SouthernBiotech, Birmingham, UK). Chicken Bu-1 is a
marker for chicken B cells and is also expressed on subsets of
macrophages and monocytes [21,22]. The monoclonal antibody
KUL01 identiﬁes chicken monocytes and macrophages as well as
interdigitating cells and activated microglia cells [23,24]. Cell
subsets were isolated using polyclonal goat anti-mouse IgG-coated
microbeads (Miltenyi Biotec, Bisley, Surrey, UK) and an autoMAC-
Spro separator (Miltenyi Biotec). The cell subsets were then
cultured with or without LPS (400 ng/ml) for 24 h. Heterophils
were isolated from 4-week-old chickens as described [25]. Brieﬂy,
heterophils were isolated from peripheral blood of eight chickens
of a Salmonella enteritidis-susceptible commercial line (line B) at 4
weeks of age, on three separate occasions; in total, therefore, 24
birds were used as cell donors.
2.3. Total RNA isolation
RNA from the tissues and cells described above was extracted
using an RNeasy Mini kit following the manufacturer’s instruc-
tions. To avoid contamination with genomic DNA, as CD14 is a
single exon gene, the samples were exposed to an on-column
treatment with RNase-free DNase I (Qiagen) for 60 min at room
temperature (RT). The RNA was eluted in RNase-free water and
stored at 80 8C until required.
2.4. Real-time quantitative RT-PCR analysis of chCD14 mRNA
expression
ChCD14 mRNA levels in different tissues and lymphoid cells
were quantiﬁed using a well-described method (e.g. [19,26–28]).
Primers and probe were designed using the Primer Express
software program (PE Applied Biosystems, Warrington, UK).
Details are given in Table 1. All probes were labelled with the
ﬂuorescent reporter dye 5-carboxyﬂuorescein (FAM) at the 50 end
and the quencher N,N,N,N0-tetramethyl-6-carboxyrhodamine
(TAMRA) at the 30 end.
Real-time quantitative RT-PCRwas performed using the Reverse
Transcriptase qPCR Master Mix RT-PCR kit (Eurogentec, Seraing,
Belgium). Ampliﬁcation and detection of speciﬁc products were
performed using the ABI PRISM 7700 Sequence Detection System
(Applied Biosystems) with the following cycle proﬁle: one cycle of
50 8C for2 min, 60 8C for30 min, and95 8C for5 min, and40cycles of
94 8C for 20 s, 59 8C for 1 min. Quantiﬁcation was based on the
increased ﬂuorescence detected due to hydrolysis of the target-
speciﬁc probes by the 50-exonuclease activity of the rTth DNA
polymerase during PCR ampliﬁcation. The passive reference dye 6-
carboxy-c-rhodamine, which is not involved in ampliﬁcation, was
used for normalization of the reporter signal. Results are expressed
in terms of the threshold cycle value (Ct), the cycle at which the
change in the reporter dye passes a signiﬁcance threshold (DRn).
To account for variation in sampling and RNA preparation, the
Ct values for CD14-speciﬁc product for each sample were
standardised using the Ct value of 28S rRNA product for the same
sample. To normalise RNA levels between samples within an
experiment, the mean Ct value for 28S rRNA-speciﬁc product was
calculated by pooling values from all samples in that experiment.
Tube-to-tube variations in 28S rRNA Ct values about the
experimental mean were calculated. The slope of the 28S rRNA
log10 dilution series regression line was used to calculate
differences in input total RNA. Using the slopes of the respective
CD14 or 28S rRNA log10 dilution series regression lines, the
difference in input total RNA, as represented by the 28S rRNA, was
then used to adjust CD14-speciﬁc Ct values, as follows: corrected
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Nt = experimental 28S mean, Ct0 = mean 28S of sample, S = CD14
slope, S0 = 28S slope. Results were then expressed as 40-Ct values.
2.5. Transient expression of chCD14 in COS-7 cells
COS-7 cells were routinely grown in DMEM (Invitrogen)
containing 10% FCS (PAA Laboratories, Linz, Austria), 1% nones-
sential amino acids, 1% L-glutamine, 1 U/ml penicillin, and 1mg/ml
streptomycin at 37 8C in 5% CO2 and passaged using standard
conditions [29].
Pre-warmed medium was added to each chamber of chamber
slides (Lab-TekTM Chamber SlideTM System, Nunc, VWR, Lutter-
worth, UK), 500ml perwell for 4-chamber slides. Trypsinised COS-7
cells were added to each well (1 105 cells/well), left at RT forFig. 1.Nucleotide (nt) and deduced amino acid (aa) sequences of chCD14. Numbers to the
1–18) is shown in bold and the predicted trans-membrane region is underlined. The p10 min toallowcells to settle and then returned to37 8C for18–24 h.
Growth medium was aspirated and Hepes-buffered DMEM (HBD,
700ml) containing 3mg DNA (p3XFLAG-CMVTM-8::chCD14 or
pCDM8::huCD14 [30]), 258mg chloroquine, and 600mg/ml
DEAE-dextran was added to the cells, which were then incubated
for 4 h at 37 8C in 5% CO2. The transfection medium was then
removed and cells washed once with PBS. HBD containing 10%
DMSO was added for 2 min, removed, replaced with 700ml of
growth medium and incubated for 40–60 h. One chamber on each
slide was washed twice with cold PBS and incubated with
phosphatidylinositol-speciﬁc phospholipase C (PI-PLC) (1.0 U/ml,
Invitrogen) at 4 8C for 30min and the other three chambers were
incubated with PBS only. Afterwards the whole slides were washed
twice with cold PBS, ﬁxed in acetone and incubated with PBS/1.0%
BSA/0.01% NaN3 for 1 h at RT in a humidiﬁed chamber. Mouse anti-left of each row refer to nt and aa position alternately. The putative signal peptide (aa
otential N-linked glycosylation sites (Asn-X-Thr/Ser) are in bold and underlined.
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to the chamber containing COS-7 cells transfected with p3XFLAG-
CMVTM-8::chCD14. Appropriately diluted mouse anti-human CD14
mAb (UCMH1) was added to the chambers containing COS-7 cells
transfected with pCDM8::huCD14 and one chamber transfected
with p3XFLAG-CMVTM-8::chCD14. The slides were incubated at RT
for 1 h and thenwashedwith PBS/0.05%Tween20. Alexa Fluor1568
goat anti-mouse IgG (H + L) (Invitrogen) was then added for 1 h at
RT. 40,6-Diamidino-2-phenylindole (DAPI, Sigma–Aldrich) was used
to detect the nuclei. A microscope with UV light (Leica DM IRB) was
used for imaging. Positively staining cells were easily identiﬁable as
red-coloured cells and cell nuclei were blue.
Flow cytometry analysis was used to detect the expression of
chCD14. Brieﬂy, COS-7 cells were cultured in T75 ﬂasks and
transfectedwith p3XFLAG-CMVTM-8::chCD14 or pCDM8::huCD14.
48 h post-transfection, cells were trypsinised and divided into two
aliquots. One aliquot of cells was incubated with PI-PLC (1.0 U/ml,
Invitrogen) at 4 8C for 30 min and the other with PBS only. Cells
were then incubated with mouse anti-FLAG M2 mAb or anti-Fig. 2.Alignment of the predicted aa sequence of chCD14with its counterparts fromdiffer
Equus caballus (horse) AY731081,Homo sapiens (human) NM_000591, Bos taurus (cow) NM
optimal alignment are indicated by dashes. Conserved cysteines are indicated by ast
conserved N-linked glycosylation sites indicated by ‘+++’. The12 potential leucine-rich r
trans-membrane (TM) and cytoplasmic domains of chCD14 are underlined.human CD14 mAb. FITC-labelled F(ab0)2 fragments of polyclonal
goat anti-mouse immunoglobulins (DAKO, Ely, Cambridgeshire,
UK) were used as secondary antibodies (Ab). For all the labelling
steps, cells (0.5–1.0  106 cells/ml) were incubated for 10 min at
RT with appropriate dilutions of the primary or secondary Ab in U-
bottomed 96-well microtiter plates with two washes between
each step. PBS containing 1.0% BSA and 0.1% NaN3 was used as
dilution and washing buffer. After the ﬁnal wash, cells analysed on
a FACSCalibur (BD Biosciences, Oxford, UK).
3. Results and discussion
3.1. Cloning and sequence analysis of chCD14 cDNA
In man, the CD14 gene is on chromosome 5 in a region which
contains a cluster of genes that encode several myeloid-speciﬁc
growth factor and receptor genes, includingplatelet-derived growth
factor receptor (PDGFR), beta-2-adrenergic receptor (ADRB2R),
endothelial cell growth factor (ECGF) [16] and heparin-bindingent species: Rattus norvegicus (rat) NM_021744,Musmusculus (mouse) NM_009841,
_174008. Shaded areas represent conservation of aa similarity. Gaps introduced for
erisks, with the mammalian disulphide bridges drawn above the sequences, and
epeats in chCD14 are indicated under the sequences with thick bars. The potential
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chromosome 18 which also contains at least ﬁve genes encoding
receptors (PDGFR, ADRB2R, Ia-associated invariant chain (Ii),
glucocorticoid receptor (Grl-1) and colony stimulating factor 1
receptor (CSF-1R or Fms)) [15]. Thus CD14 forms a conserved
syntenic group with these growth factor and growth factor
receptor genes [15]. We used the huCD14 sequence to search the
chicken genome in Ensembl (by BLAST) and predicted the cDNA
sequence of the chicken homologue of huCD14. It is encoded
on chicken chromosome 13, Contig158.29, alongside several
receptor genes, such as Cadherin-related neuronal receptor
(CNR, ENSGALG00000000760), ADRB2R (ENSGALG00000002808)
and heparin-binding growth factor 1 precursor (HBGF,
ENSGALG00000007343). This suggests that, as in mammals,
CD14 and the growth factor and growth factor receptor genes
show conservation of synteny in the chicken.
The Ensembl novel protein coding prediction
ENSGALT00000034888 identiﬁes part of chCD14, but incorrectly
as part of a three-exon gene spanning contigs 158.26-29,
and overlapping another novel protein coding prediction
ENSGALT00000001235. However, the ab initio Genscan translation
prediction GENSCAN00000074788 actually correctly identiﬁes
chCD14, although of course it is not annotated as such.
RNA isolated from chicken bone marrow cells was used as a
template to amplify chCD14 cDNAwith primers CD14-1 and CD14-
2 and nested primers CD14-3 and CD14-4. The PCR product was
1398 bp in length with a high-GC content (Fig. 1). The primary
structure of the chCD14 protein was deduced from the cDNA and
consists of 465 aa (Fig. 1). A potential signal peptide cleavage site
was predicted in the aa sequence (SignalP 3.0 server) between
residues 18 and 19. ChCD14 contains nineteen cysteine residues,Fig. 3. (A) Expression patterns of chCD14 in chicken lymphoid tissues (1–7), non-lymp
derived monocytes (g), blood-derived macrophages (h) and blood-derived heterophils
values  S.E.: 1, thymus; 2, spleen; 3, bursa of Fabricius; 4, Harderian gland; 5, caecal tons
kidney; vi, lung; vii, skin; a, unstimulated splenocytes; b, ConA-stimulated splenocytes; c, un
PHA-stimulated thymocytes. (B) Expression patterns of chCD14 in chicken splenocyte subset
5, TCR1+ cells; 6, LPS-stimulated TCR1+ cells; 7, TCR2+ cells; 8, LPS-stimulated TCR2+ cells; 9
cells; 13, KUL01+ cells; 14, LPS-stimulated KUL01+ cells.eight of which are conserved between chicken and mammals. In
mammalian CD14, there are four disulphide bridges between these
eight conserved cysteines (as shown in Fig. 2), suggesting that
chCD14 has a similar secondary structure. There are ﬁve potential
N-linked glycosylation sites (Asn-X-Thr/Ser), two of which are
conserved with mammalian CD14. Alignment of the aa sequences
of chCD14 and mammalian CD14 (Fig. 2) reveals 31–34% aa
identity. As shown in Fig. 2, chCD14 contains 12 leucine-rich
repeats (LRR, LxxLxLxx) [31], as opposed to the 11 found in
mammalian CD14 [15]. LRRs provide a structural framework for
the formation of protein–protein interactions [31].
In mammals, CD14 is a glycosylphosphatidylinositol (GPI)-
anchored protein [2]. These proteins lack a trans-membrane
domain, have no cytoplasmic tail, and are, therefore, located
exclusively on the extracellular side of the plasma membrane. GPI
proteins have been found in awide variety of eukaryotes, including
mammals, chickens and ﬁsh. On average,0.5% of cellular proteins
in eukaryotes are GPI-anchored [32]. Unlike in mammals, protein
structure analysis suggests that chCD14 is not a GPI-anchored
protein but a type I trans-membrane protein. The predicted aa
sequence comprises an extracellular domain of 417 aa, followed by
a 23-aa trans-membrane segment, and a 25-aa intracytoplasmic
region. There are no obvious signalling motifs in the potential
cytoplasmic tail, as assessed directly by eye and also by using the
SCANSITE program (http://scansite.mit.edu/) [33].
3.2. Expression of chicken CD14 mRNA in different tissues and cell
populations
Expression of chCD14 mRNA in lymphoid and non-lymphoid
tissues and lymphoid cells was assessed by real-time quantitativehoid tissues (i–vii), stimulated/non-stimulated chicken lymphocytes (a–f), blood-
(i), as measured by real-time quantitative RT-PCR, with results expressed as 40-Ct
il; 6, Meckel’s diverticulum; 7, bone marrow; i, brain; ii, muscle; iii, heart; iv, liver; v,
stimulated bursal cells; d, PMA-stimulated bursal cells; e, unstimulated thymocytes; f,
s: 1, CD4+ cells; 2, LPS-stimulated CD4+ cells; 3, CD8+ cells; 4, LPS-stimulated CD8+ cells;
, TCR3+ cells; 10, LPS-stimulated TCR3+ cells; 11, Bu-1+ cells; 12, LPS-stimulated Bu-1+
Z. Wu et al. / Developmental and Comparative Immunology 33 (2009) 97–104102RT-PCR (Fig. 3). ChCD14 mRNA was constitutively expressed in all
the lymphoid and non-lymphoid tissues tested except for muscle.
ChCD14 was also expressed in splenocytes, bursal cells and,
thymocytes. Expression was down-regulated in mitogen-stimu-
lated splenocytes and bursal cells (P < 0.05) but expression was
not signiﬁcantly altered (P > 0.05) in mitogen-stimulated thymo-
cytes. ChCD14 was highly expressed in monocyte-derived macro-
phages and blood monocytes. ChCD14 was also expressed in
blood-derived heterophils.
ChCD14 mRNA was detected in all splenocyte subsets. The
general distributions of CD14 mRNA that we found in chicken
tissues and cells were in accordance with the expression patterns
of CD14 mRNA in mammals [13,34,35]. However, KUL01+
splenocytes showed high expression of chCD14, as did blood
monocytes/macrophages, and LPS stimulation signiﬁcantly
(P < 0.05) up-regulated the expression of chCD14 in those cells.
Up-regulated expression of CD14 mRNA by LPS stimulation is also
seen in mammals [36].
3.3. Transient expression of chicken CD14 in COS cells
To detect if chCD14 is a GPI-anchored protein as it is in
mammals, COS-7 cells were transfected with p3XFLAG-CMVTM-
8::chCD14 or pCDM8::huCD14, and incubated with or without PI-Fig. 4. Detection of chCD14 expressed by COS-7 cells. (A–C and G) COS-7 cells trans
incubation, stained with anti-FLAG mAb M2; (C) with PI-PLC incubation, stained with a
UCMH1. (D–F) COS-7 cells transfected with pCDM8::huCD14. (D) isotype control; (E) w
incubation, stained with anti-huCD14 mAb UCMH1.PLC, before staining with an anti-FLAG or anti-huCD14 mAb as
appropriate. Fig. 4 clearly shows that COS-7 cells transfected with
huCD14 stained with the anti-human CD14 mAb (Fig. 4E), and this
staining was lost when the transfected cells were pre-treated with
PI-PLC (Fig. 4F), which releases GPI-anchored proteins. In contrast,
COS-7 cells transfected with FLAG-tagged chCD14 stainedwith the
anti-FLAG mAb (Fig. 4B), and this staining was retained following
PI-PLC pre-treatment (Fig. 4C), suggesting that chCD14 is not GPI-
anchored. Fig. 5 shows FACS analysis of COS-7 cells transfected and
treated as described previously. Without PI-PLC treatment,
approximately10% of COS-7 cells were positive for either huCD14
or chCD14. Following PI-PLC treatment, only 2.7% of COS-7 cells
were positive for huCD14 but a similar proportion (9.3%) to non-
treated cells were positive for chCD14. These results again suggest
that chCD14 is not GPI-anchored.
Although there is broad species-overlapping reactivity of
mAbs directed against CD14, anti-huCD14 mAbs (clones
CAM36A, UCHM1, TU¨K4 and M5E2) did not cross-react with
chicken cells, as tested by Saalmuller et al. [37]. To conﬁrm this
lack of reported cross-reactivity, chCD14 was expressed in COS-7
cells and stained with an anti-huCD14 antibody (UCHM1)
(Fig. 4G). There was no apparent cross-reactivity. Either the
anti-huCD14 antibody does not cross-react with chCD14, or the
binding afﬁnity is low. We also used UCHM1 to stain chickenfected with p3XFLAG-CMVTM-8::chCD14. (A) Isotype control; (B) without PI-PLC
nti-FLAG mAb M2; (G) without PI-PLC incubation, stained with anti-huCD14 mAb
ithout PI-PLC incubation, stained with anti-huCD14 mAb UCMH1; (F) with PI-PLC
Fig. 5.Detection of chCD14 expressed by COS-7 cells by ﬂow cytometry. (A–C) COS-7 cells transfectedwith p3XFLAG-CMVTM-8::chCD14 and stainedwith anti-FLAGmAbM2;
(D–F) COS-7 cells transfected with pCDM8::huCD14 and stained with anti-huCD14 mAb UCMH1. (A and D) Isotype control; (B and E) without PI-PLC incubation; (C and F)
with PI-PLC incubation.
Z. Wu et al. / Developmental and Comparative Immunology 33 (2009) 97–104 103spleen cryo-sections, and again did not ﬁnd any cross-reactivity
(data not shown).
3.4. Summary
In summary, chCD14 was cloned and molecularly character-
ized. Analysis of chCD14mRNA expression levels in chicken tissues
and cells showed a higher expression in chicken blood-derived
monocytes, monocyte-derived macrophages and KUL01+ spleno-
cytes.
ChCD14 shares many structural features with mammalian
CD14, including eight conserved cysteines with the potential to
form four disulphide bridges, and eleven conserved LRRs (and an
extra potential chicken-speciﬁc LRR). Unlike mammalian CD14,
chCD14 appears to have trans-membrane and cytoplasmic
domains, suggesting that it is not GPI-anchored. This has important
implications for the role of CD14 in the chicken’s response to LPS. A
GPI-anchored protein in general is more mobile in the cell
membrane than one that is trans-membrane. In mammals, and
presumably in the chicken, CD14 is a co-receptor for LPS with LBP,
MD-2 and TLR4. The kinetics of such interactions, and therefore
presumably the response to LPS, may well be compromised by
chCD14 being trans-membrane. We have here provided evidence
that chCD14 is not GPI-anchored and this may, in part, explain
anecdotal reports that chicken cells respond less well to LPS than
the equivalent mammalian cells.
Acknowledgements
This research was undertaken with the ﬁnancial support of
Intervet. The authorswould like to thank Lai Shan Kwong (Institute
for Animal Health, Compton, UK) for kindly providing thepCDM8::huCD14 plasmid, and Mike Kogut (USDA, College Station,
Texas, USA) for providing the heterophil mRNA.
References
[1] Schutt C. CD14. Int J Biochem Cell Biol 1999;31(5):545–9.
[2] Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte
differentiation antigen, CD14, is anchored to the cell membrane by a phos-
phatidylinositol linkage. J Immunol 1988;141(2):547–52.
[3] Labeta MO, Durieux JJ, Fernandez N, Herrmann R, Ferrara P. Release from a
human monocyte-like cell line of two different soluble forms of the lipopo-
lysaccharide receptor, CD14. Eur J Immunol 1993;23(9):2144–51.
[4] Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14
on stimulated human monocytes. J Immunol 1991;147(5):1567–74.
[5] Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for
complexes of lipopolysaccharide (LPS) and LPS binding protein. Science
1990;249(4975):1431–3.
[6] Miyake K. Innate recognition of lipopolysaccharide by CD14 and toll-like
receptor 4-MD-2: unique roles for MD-2. Int Immunopharmacol 2003;3(1):
119–28.
[7] Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, et al.
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to
CD14. J Exp Med 1994;179(1):269–77.
[8] da Silva Correia J, Ulevitch RJ. MD-2 and TLR4 N-linked glycosylations are
important for a functional lipopolysaccharide receptor. J Biol Chem
2002;277(3):1845–54.
[9] Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, et al. Resistance
to endotoxin shock and reduced dissemination of gram-negative bacteria in
CD14-deﬁcient mice. Immunity 1996;4(4):407–14.
[10] Haziot A, Ferrero E, Lin XY, Stewart CL, Goyert SM. CD14-deﬁcient mice are
exquisitely insensitive to the effects of LPS. Prog Clin Biol Res 1995;392:
349–51.
[11] Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, et al. Transgenic mice
expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl
Acad Sci USA 1993;90(6):2380–4.
[12] Gupta D, Kirkland TN, Viriyakosol S, Dziarski R. CD14 is a cell-activating
receptor for bacterial peptidoglycan. J Biol Chem 1996;271(38):23310–6.
[13] Grifﬁn JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentia-
tion antigens on normal andmalignantmyeloid cells. J Clin Invest 1981;68(4):
932–41.
Z. Wu et al. / Developmental and Comparative Immunology 33 (2009) 97–104104[14] Jersmann HP. Time to abandon dogma: CD14 is expressed by non-myeloid
lineage cells. Immunol Cell Biol 2005;83(5):462–7.
[15] Ferrero E, Hsieh CL, Francke U, Goyert SM. CD14 is a member of the family of
leucine-rich proteins and is encoded by a gene syntenicwithmultiple receptor
genes. J Immunol 1990;145(1):331–6.
[16] Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM. The
CD14 monocyte differentiation antigen maps to a region encoding growth
factors and receptors. Science 1988;239(4839):497–500.
[17] Matsuura K, Setoguchi M, Nasu N, Higuchi Y, Yoshida S, Akizuki S, et al.
Nucleotide and amino acid sequences of the mouse CD14 gene. Nucl Acid Res
1989;17(5):2132.
[18] Kim JI, Lee CJ, JinMS, Lee CH, Paik SG, Lee H, et al. Crystal structure of CD14 and
its implications for lipopolysaccharide signaling. J Biol Chem 2005;280(12):
11347–51.
[19] Hughes S, Poh TY, Bumstead N, Kaiser P. Re-evaluation of the chicken MIP
family of chemokines and their receptors suggests that CCL5 is the prototypic
MIP family chemokine, and that different species have developed different
repertoires of both the CC chemokines and their receptors. Dev Comp Immu-
nol 2007;31(1):72–86.
[20] Butter C, Staines K, Baaten B, Smith L, Davison TF. Route of challenge is critical
in determining the clinical outcome of infectionwith a very virulent oncogenic
herpesvirus, Marek’s disease virus. Avian Pathol 2007;36(2):93–9.
[21] Tregaskes CA, Bumstead N, Davison TF, Young JR. Chicken B-cell marker chB6
(Bu-1) is a highly glycosylated protein of unique structure. Immunogenetics
1996;44(3):212–7.
[22] Rothwell CJ, Vervelde L, Davison TF. Identiﬁcation of chicken Bu-1 alloantigens
using the monoclonal antibody AV20. Vet Immunol Immunopathol
1996;55(1–3):225–34.
[23] Mast J, Goddeeris BM, Peeters K, Vandesande F, Berghman LR. Characterisa-
tion of chicken monocytes, macrophages and interdigitating cells by the
monoclonal antibody KUL01. Vet Immunol Immunopathol 1998;61(2–
4):343–57.
[24] Wigley P, Berchieri Jr A, Page KL, Smith AL, Barrow PA. Salmonella enterica
serovar Pullorum persists in splenic macrophages and in the reproductive
tract during persistent, disease-free carriage in chickens. Infect Immun
2001;69(12):7873–9.[25] Swaggerty CL, Kaiser P, Rothwell L, Pevzner IY, Kogut MH. Heterophil cytokine
mRNA proﬁles from genetically distinct lines of chickens with differential
heterophil-mediated innate immune responses. Avian Pathol 2006;35(2):
102–8.
[26] Harrison SM, Dove BK, Rothwell L, Kaiser P, Tarpey I, Brooks G, et al. Down
regulation of cyclin D1 by the avian coronavirus infectious bronchitis virus.
FEBS Lett 2007;581(7):1275–86.
[27] Harrison SM, Tarpey I, Rothwell L, Kaiser P, Hiscox JA. Lithium chloride inhibits
the coronavirus infectious bronchitis virus in cell culture. Avian Pathol
2007;36(2):109–14.
[28] Eldaghayes I, Rothwell L, Williams A, Withers D, Balu S, Davison F, et al.
Infectious bursal disease virus: strains that differ in virulence differentially
modulate the innate immune response to infection in the chicken bursa. Viral
Immunol 2006;19(1):83–91.
[29] Tregaskes CA, Young JR. Cloning of chicken lymphocyte marker cDNAs from
eukaryotic expression libraries. In: Lefkovits I, editor. Immunology methods
manual, vol. 4. San Diego, CA: Academic Press; 1997. p. 2295.
[30] Zhang G, Young JR, Tregaskes CA, Sopp P, Howard CJ. Identiﬁcation of a novel
class of mammalian Fc gamma receptor. J Immunol 1995;155(3):1534–41.
[31] Kajava AV. Structural diversity of leucine-rich repeat proteins. J Mol Biol
1998;277(3):519–27.
[32] Mayor S, Riezman H. Sorting GPI-anchored proteins. Nat Rev Mol Cell Biol
2004;5(2):110–20.
[33] Obenauer JC, Cantley LC, Yaffe MB. Scansite 2.0: proteome-wide prediction of
cell signaling interactions using short sequence motifs. Nucl Acid Res
2003;31(13):3635–41.
[34] NishimuraM, Naito S. Tissue-speciﬁcmRNA expression proﬁles of human toll-
like receptors and related genes. Biol Pharm Bull 2005;28(5):886–92.
[35] Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ. Murine CD14 gene expres-
sion in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J
Exp Med 1995;181(3):857–66.
[36] Ikeda A, Takata M, Taniguchi T, Sekikawa K. Molecular cloning of bovine CD14
gene. J Vet Med Sci 1997;59(8):715–9.
[37] Saalmuller A, Lunney JK, Daubenberger C, Davis W, Fischer U, Gobel TW, et al.
Summary of the animal homologue section of HLDA8. Cell Immunol
2005;236(1–2):51–8.
